Doç. Dr. SEMİH BAŞCI

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis , cilt.60, sa.1, ss.102955, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

46. Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: A single center experience

Batgi H., Basci S., Dal M. S., Kizil Çakar M., Uncu Ulu B., Yigenoglu T. N., et al.

Turkish Journal of Medical Sciences , cilt.51, sa.2, ss.685-692, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

47. Is classical Hodgkin lymphoma a different disease in the elderly? A single-center retrospective cohort study

Yildiz J., Ulu B., Yiğenoğlu T., Başçi S., Darçin T., Bakirtaş M., et al.

European Review for Medical and Pharmacological Sciences , cilt.25, sa.10, ss.3655-3660, 2021 (SCI-Expanded)

48. A Comparison of the BEAM and BuCyE Conditioning Regimens for Autologous Stem Cell Transplantation in Lymphoma: A Single-Center Experience

BATGİ H., BAŞCI S., YAMAN S., UNCU ULU B., YİĞENOĞLU T. N., DAL M. S., et al.

ACTA ONCOLOGICA TURCICA , cilt.54, sa.3, ss.87-95, 2021 (Hakemli Dergi)

49. COVID-19 clinical course and blood groups: Turkish population-based study

Dal M. S., Ata N., ALTUNTAŞ F., Başci S., Yiğenoğlu T. N., Korkmaz S., et al.

Turkish Journal of Medical Sciences , cilt.51, sa.4, ss.1659-1664, 2021 (SCI-Expanded)

50. Tyrosine kinase inhibitors and COVID-19

Semih B., Tuğçe Nur Y., Mehmet Sinan D., Serdal K., Burhan T., Fevzi A.

Journal of Oncology Pharmacy Practice , cilt.26, sa.8, ss.2072-2073, 2020 (SCI-Expanded)

51. Early Relapse After Autologous Stem Cell Transplantation in Multiple Myeloma is Still Prognostic in The Era of Novel Agents

BAŞCI S., YİĞENOĞLU T. N., UNCU ULU B., BAKIRTAŞ M., ŞAHİN D., DARÇIN T., et al.

Medical Laboratory Technology Journal , cilt.6, sa.2, ss.92-99, 2020 (Hakemli Dergi)

52. The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience

Batgi H., Merdin A., Dal M. S., Kızıl Çakar M., Yıldız J., Başçı S., et al.

Journal of Oncology Pharmacy Practice , cilt.26, sa.8, ss.1857-1863, 2020 (SCI-Expanded)

53. Is Autologous Stem Cell Transplantation a Risk For Divorce in Lymphoma Survivors?

YILDIZ J., YİĞENOĞLU T. N., MERDİN A., UNCU ULU B., BAŞCI S., DARÇIN T., et al.

ACTA ONCOLOGICA TURCICA , cilt.53, sa.3, ss.469-474, 2020 (Hakemli Dergi)

54. Erişkin Başlangıçlı Langerhans Hücreli Histiyositozis Tedavisinde Vinblastin Kemoterapisinin Yeri – Ankara Onkoloji Hastanesi Deneyimi

TETİK A., UNCU ULU B., BAKIRTAŞ M., YİĞENOĞLU T. N., YILDIZ J., BAŞCI S., et al.

ACTA ONCOLOGICA TURCICA , cilt.53, sa.3, ss.492-499, 2020 (Hakemli Dergi)

55. Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors

Başcı S., Ata N., ALTUNTAŞ F., Yiğenoğlu T. N., Dal M. S., Korkmaz S., et al.

Journal of Oncology Pharmacy Practice , cilt.26, sa.7, ss.1676-1682, 2020 (SCI-Expanded)

56. The Coexistence of Hyperimmunoglobulin E Syndrome and Myelodysplastic Syndrome

Secilmis S., Bozan E., Darcin T., Yaman S., Baysal N. A., Yigenoglu T. N., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.20, 2020 (SCI-Expanded)

57. Combination of Venetoclax and Hypomethylating Agents in Relapsed/Refractory Acute Myeloid Leukemia: Single-Center Clinical Experience

Secilmis S., Bozan E., Darcin T., Yaman S., Yigenoglu T., Ulu B. U., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.20, 2020 (SCI-Expanded)

58. One Year Remission with Allogeneic Stem Cell Transplantation After Achieving Complete Response by Polatuzumab Vedotin for the Treatment of Refractory Diffuse Large B-Cell Lymphoma

Yaman S., Yigenoglu T. N., Ulu B. U., Bozan E., Secilmis S., Darcin T., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.20, 2020 (SCI-Expanded)

59. Adult aplastic anemia patients can maintain remission after allogeneic hematopoietic stem cell transplantation in a mixed chimeric state

BAŞCI S., YİĞENOĞLU T. N., BAKIRTAŞ M., UNCU ULU B., ŞAHİN D., DARÇIN T., et al.

Journal of Surgery and Medicine , cilt.4, sa.9, ss.729-732, 2020 (Hakemli Dergi)

60. The Relationship Between ABO and Rh Blood Groups with Acute Lymphoblastic Leukemia

BAŞCI S., YİĞENOĞLU T. N., ŞAHİN D., Saygılı Ö., BAKIRTAŞ M., UNCU ULU B., et al.

ACTA ONCOLOGICA TURCICA , cilt.53, sa.2, ss.357-361, 2020 (Hakemli Dergi)

61. Blood group A is a negative risk factor for peripheric blood stem cell mobilization in allogeneic donors

YİĞENOĞLU T. N., BAKIRTAŞ M., BAŞCI S., UNCU ULU B., ŞAHİN D., KILINÇ A., et al.

Medical Science and Discovery , cilt.7, sa.6, ss.505-508, 2020 (Hakemli Dergi)

62. The relationship between blood groups and acute myeloid leukemia

ŞAHİN D., BAŞCI S., TEMİZEL TAŞCI A., UNCU ULU B., BATGİ H., BAYSAL N. A., et al.

JOURNAL OF HEALTH SCIENCES AND MEDICINE , cilt.3, sa.3, ss.221-224, 2020 (Hakemli Dergi)

63. Second allogeneic stem cell transplantation in acute leukemia patients: single-centre experience

BAKIRTAŞ M., YİĞENOĞLU T. N., BAŞCI S., UNCU ULU B., ÖZCAN N., İSKENDER D., et al.

JURNAL TEKNOLOGI LABORATORIUM , cilt.9, sa.1, ss.87-96, 2020 (Hakemli Dergi)

64. Evaluation of neutropenia-related outcomes in Hodgkin's lymphoma patients with moderate or severe neutropenia who received ABVD chemotherapy without using granulocyte-colony stimulating factor

Merdin A., Çakar M. K., Dal M. S., Mert D., Yıldız J., Başçı S., et al.

Journal of Oncology Pharmacy Practice , cilt.26, sa.4, ss.929-932, 2020 (SCI-Expanded)

65. The Value Of International Staging System In Predicting Survival of Multiple Myeloma Patients With Renal Failure

YİĞENOĞLU T. N., BAŞCI S., BAKIRTAŞ M., UNCU ULU B., ŞAHİN D., DARÇIN T., et al.

Dicle Tıp Dergisi , cilt.47, sa.2, ss.237-242, 2020 (Hakemli Dergi)

66. The effect of serum vitamin B12, folate, ferritin levels and transferrin saturation on stem cell mobilization in allogeneic donors

Yiğenoğlu T. N., Başcı S., Bakırtaş M., Ulu B. U., Kılınç A., Şahin D., et al.

Transfusion and Apheresis Science , cilt.59, sa.3, 2020 (SCI-Expanded)

67. The effect of smoking on stem cell mobilization in allogeneic donors

YİĞENOĞLU T. N., BAŞCI S., ŞAHİN D., BAKIRTAŞ M., KILINÇ A., UNCU ULU B., et al.

JOURNAL OF HEALTH SCIENCES AND MEDICINE , cilt.3, sa.3, ss.291-294, 2020 (Hakemli Dergi)

68. Inferior prognosis in poor mobilizing myeloma patients

Yiğenoğlu T. N., Başcı S., Ulu B. U., Bakırtaş M., Kılınç A., Şahin D., et al.

Transfusion and Apheresis Science , cilt.59, sa.3, 2020 (SCI-Expanded)

69. Evaluation of seasonal changes in the diagnosis of acute leukemia in Turkey

Başci S.

Medical Science and Discovery , cilt.7, ss.501-504, 2020 (Hakemli Dergi)

70. OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION WITH ACTIVE DISEASE IN ACUTE MYELOID LEUKEMIA

BAKIRTAŞ M., YİĞENOĞLU T. N., BAŞCI S., UNCU ULU B., ÖZCAN N., KIZIL ÇAKAR M., et al.

SANAMED , cilt.15, sa.1, ss.15-19, 2020 (Hakemli Dergi)

71. Stem Cell Transplantation and Medical Tourism at Ankara Oncology Training and Research Hospital

ŞAHİN D., YİĞENOĞLU T. N., BAŞCI S., UNCU ULU B., DARÇIN T., BAKIRTAŞ M., et al.

ACTA ONCOLOGICA TURCICA , cilt.53, sa.1, ss.113-116, 2020 (Hakemli Dergi)

72. Otolog Kök Hücre Nakli Sonrası Nüks Multipl Myelom Hastalarında Allojenik Kök Hücre Transplantasyonu: Tek Merkez Deneyimi

BAKIRTAŞ M., UNCU ULU B., BAŞCI S., YİĞENOĞLU T. N., YILDIZ J., MERDİN A., et al.

ACTA ONCOLOGICA TURCICA , cilt.53, sa.1, ss.108-112, 2020 (Hakemli Dergi)

73. The Outcome of Autologous Stem Cell Transplantation in Adolescent and Young Adult Patients with Multiple Myeloma

YİĞENOĞLU T. N., BAŞCI S., UNCU ULU B., BAKIRTAŞ M., ŞAHİN D., DARÇIN T., et al.

EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY , cilt.4, sa.1, ss.79-83, 2020 (ESCI)

74. The effect of high-dose cytarabine followed by autologous hematopoietic stem cell transplantation on the outcome of patients with mantle cell lymphoma

Çakar M. K., Tekgündüz E., Dal M. S., Merdin A., Başçı S., Uğur B., et al.

Journal of Oncology Pharmacy Practice , cilt.26, sa.2, ss.273-278, 2020 (SCI-Expanded)

75. Analysis of pre-chemotherapy WBC, PLT, monocyte, hemoglobin, and MPV levels in acute myeloid leukemia patients with WT1, FLT3, or NPM gene mutations

Merdin A., Dal M. S., Çakar M. K., Yildiz J., Ulu B. U., Batgi H., et al.

Medicine (United States) , cilt.99, sa.14, 2020 (SCI-Expanded)

76. Polatuzumab Vedotin in Combination with Bendamustine Plus Rituximab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Our Experience

Darcin T., Yigenoglu T. N., Sahin D., Bakirtas M., BAŞCI S., Merdin A., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.19, 2019 (SCI-Expanded)

77. The Relationship Between ABO and Rhesus Blood Groups and Acute Lymphoblastic Leukemia

Sahin D., Yigenoglu T., Darcin T., BAŞCI S., Saygili O., Ulu B., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.19, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

78. Inotuzumab Ozogamicin Salvage Monotherapy for the Treatment of Relapsed/Refractory Acute B-Cell Lymphoblastic Leukemia

Darcin T., Yigenoglu T. N., Sahin D., Bakirtas M., BAŞCI S., Merdin A., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.19, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

79. Handgrip Strength and Serum Uric Acid Levels are Associated with Dialysis-Malnutrition Scores in Chronic Hemodialysis Patients

BAŞCI S., ÖZKÖK A., KAÇAR M., BİLGİN S., ODABAŞ A. R.

TURKISH NEPHROLOGY, DIALYSIS AND TRANSPLANTATION JOURNAL , cilt.26, sa.3, ss.323-332, 2017 (Scopus) Sürdürülebilir Kalkınma

80. The relationship between vitamin D level and mean platelet volume in kidney transplant recipients

ŞAŞAK KUZGUN G., ORAL A., BAŞCI S.

Medeniyet medical journal , cilt.32, sa.2, ss.106-110, 2017 (Scopus)

81. Effects of the Clinical and Biochemical Features of Patients with Treatment-Resistant Primary Nephrotic Syndrome on Renal Survival

BİLGİN S., ÖZKÖK A., KÖSTEK O., BAŞCI S., ÖZKANLI S. Ş., ODABAŞ A. R.

TURKISH NEPHROLOGY, DIALYSIS AND TRANSPLANTATION JOURNAL , cilt.26, sa.1, ss.79-85, 2017 (Scopus)

82. Synthetic Cannabinoids Associated Acute Kidney Injury: Case Report

ELÇİOĞLU Ö. C., BAŞCI S., BAKAN A., AYDIN BAHAT K., ÖZLÜK M. Y., KILIÇASLAN I., et al.

Turkiye Klinikleri Journal of Nephrology , cilt.10, sa.2, ss.43-46, 2016 (Hakemli Dergi)

83. Chronic rhinosinusitis, endothelial dysfunction, and atherosclerosis

ELÇİOĞLU Ö. C., Afsar B., Bakan A., Takir M., Ozkok A., Oral A., et al.

American Journal of Rhinology and Allergy , cilt.30, sa.3, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

84. Hyperuricemia is associated with progression of IgA nephropathy

Bakan A., Oral A., ELÇİOĞLU Ö. C., Takir M., Kostek O., Ozkok A., et al.

International Urology and Nephrology , cilt.47, sa.4, ss.673-678, 2015 (SCI-Expanded)

85. Postpartum Stanford Type A Aortic Dissection: A Case Report and Review of the Literature

BALBAY E., BAŞCI S., BOZKURT İ., ÖZKÖK A., DOĞRUYOL S., ERKUŞ SİRKECİ E., et al.

Cardiology Research , cilt.4, sa.3, ss.129-132, 2013 (Hakemli Dergi)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 1

1. LENALİDOMİD TEDAVİSİ ALAN İZOLE 5Q DELESYONU OLAN MYELODİSPLASTİK SENDROM HASTASININ EKSTRAMEDULLER AKUT MYELOİD LÖSEMİYE TRANSFORMASYONU: OLGU SUNUMU

YİĞENOĞLU T. N., BAŞCI S., BAKIRTAŞ M., UNCU ULU B., ŞAHİN D., DARÇIN T., et al.

II. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, BAFRA, Kıbrıs (Kktc), 7 - 09 Şubat 2019, (Özet Bildiri)

Kitaplar 6

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

340

H-İndeks (WoS)

Atıf (Scopus)

362

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Sobiad)

H-İndeks (Sobiad)

Atıf (Diğer Toplam)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Sobiad)

H-İndeks (Sobiad)

Atıf (Diğer Toplam)

Proje

Açık Erişim